Cargando…
Tailored PGE2 Immunomodulation of moDCs by Nano-Encapsulated EP2/EP4 Antagonists
Prostaglandin E2 (PGE2) is an important maturation mediator for dendritic cells (DCs). However, increased PGE2 levels in the tumor exert immunosuppressive effects on DCs by signaling through two E-Prostanoid (EP) receptors: EP2 and EP4. Blocking EP-receptor signaling of PGE2 with antagonists is curr...
Autores principales: | Bödder, Johanna, Kok, Leanne M., Fauerbach, Jonathan A., Flórez-Grau, Georgina, de Vries, I. Jolanda M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866164/ https://www.ncbi.nlm.nih.gov/pubmed/36674907 http://dx.doi.org/10.3390/ijms24021392 |
Ejemplares similares
-
STAT Family Protein Expression and Phosphorylation State during moDC Development Is Altered by Platinum-Based Chemotherapeutics
por: de Haas, Nienke, et al.
Publicado: (2019) -
Role of the PGE(2) receptor subtypes EP1, EP2, and EP3 in repetitive traumatic brain injury
por: Catlin, James, et al.
Publicado: (2019) -
COX-2-PGE(2)-EPs in gynecological cancers
por: Ye, Yao, et al.
Publicado: (2020) -
PGE2-EP2/EP4 signaling elicits mesoCAR T cell immunosuppression in pancreatic cancer
por: Akbari, Behnia, et al.
Publicado: (2023) -
Changing prostaglandin E2 (PGE(2)) signaling during lesional progression and exacerbation of endometriosis by inhibition of PGE(2) receptor EP2 and EP4
por: Huang, Qingqing, et al.
Publicado: (2021)